Importantly, a substantial proportion (14%) of CHH patients without a molecular diagnosis carried rare variants predicted to be P or LP in genes typically associated with CPHD (e.g. <i>ROBO1</i>, <i>BRAF</i>, <i>FAT2</i>, and <i>DCHS2</i>). This evidence concerns the gene BRAF and cartilage-hair hypoplasia.